scholarly journals Avulsion Fractures of the Ischial Tuberosity: Progress of Injury, Mechanism, Clinical Manifestations, Imaging Examination, Diagnosis and Differential Diagnosis and Treatment

2018 ◽  
Vol 24 ◽  
pp. 9406-9412 ◽  
Author(s):  
Heng Liu ◽  
Yiqun Zhang ◽  
Moujie Rang ◽  
Qiang Li ◽  
Zhaowei Jiang ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Clinical Manifestations ◽  
Ischial Tuberosity ◽  
Injury Mechanism ◽  
Diagnosis And Treatment ◽  
Avulsion Fractures ◽  
Imaging Examination

Scleroderma and Related Disorders

2017 ◽  
Author(s):  
Kristine Phillips
Keyword(s):  
Differential Diagnosis ◽  
Antinuclear Antibodies ◽  
Clinical Course ◽  
Clinical Manifestations ◽  
Diagnosis And Treatment ◽  
Localized Scleroderma ◽  
Eosinophilic Fasciitis ◽  
Tomographic Images ◽  
Computed Tomographic

Scleroderma spectrum diseases are a heterogeneous group of disorders that are distinguished by abnormalities of the connective tissue in the skin and, in some cases, other organs. Each disorder may be characterized by the extent of cutaneous and internal involvement, as well as histopathologic features of skin biopsy. Scleroderma spectrum diseases include systemic scleroderma, localized scleroderma, and eosinophilic fasciitis. This chapter reviews the classification, epidemiology, etiology, pathophysiology and pathogenesis, diagnosis, differential diagnosis, treatment, outcome measures, management, and clinical course of scleroderma as well as the definition and classification, etiology/genetics, differential diagnosis, and treatment of localized scleroderma. Also discussed are the definition and classification, epidemiology, etiology/genetics/pathogenesis, diagnosis, differential diagnosis, and treatment of eosinophilic fasciitis. Tables review the classification of—and antinuclear antibodies in—scleroderma as well as the key assessments and interventions in scleroderma management. Figures illustrate the disease's presentation and clinical manifestations, including several images of scleroderma of the hands; face, palmar, and buccal telangiectasias in a patient with scleroderma; a radiograph demonstrating calcinosis of the elbow; Raynaud’s phenomenon; high-resolution computed tomographic images of diffuse cutaneous scleroderma, scleroderma and severe pulmonary hypertension, and limited cutaneous scleroderma; plus an esophagram demonstrating hypomotility. This review contains 11 highly rendered figures, 3 tables, and 72 references.

Scleroderma and Related Disorders

2017 ◽  
Author(s):  
Kristine Phillips
Keyword(s):  
Differential Diagnosis ◽  
Antinuclear Antibodies ◽  
Clinical Course ◽  
Clinical Manifestations ◽  
Diagnosis And Treatment ◽  
Localized Scleroderma ◽  
Eosinophilic Fasciitis ◽  
Tomographic Images ◽  
Computed Tomographic

Scleroderma spectrum diseases are a heterogeneous group of disorders that are distinguished by abnormalities of the connective tissue in the skin and, in some cases, other organs. Each disorder may be characterized by the extent of cutaneous and internal involvement, as well as histopathologic features of skin biopsy. Scleroderma spectrum diseases include systemic scleroderma, localized scleroderma, and eosinophilic fasciitis. This chapter reviews the classification, epidemiology, etiology, pathophysiology and pathogenesis, diagnosis, differential diagnosis, treatment, outcome measures, management, and clinical course of scleroderma as well as the definition and classification, etiology/genetics, differential diagnosis, and treatment of localized scleroderma. Also discussed are the definition and classification, epidemiology, etiology/genetics/pathogenesis, diagnosis, differential diagnosis, and treatment of eosinophilic fasciitis. Tables review the classification of—and antinuclear antibodies in—scleroderma as well as the key assessments and interventions in scleroderma management. Figures illustrate the disease's presentation and clinical manifestations, including several images of scleroderma of the hands; face, palmar, and buccal telangiectasias in a patient with scleroderma; a radiograph demonstrating calcinosis of the elbow; Raynaud’s phenomenon; high-resolution computed tomographic images of diffuse cutaneous scleroderma, scleroderma and severe pulmonary hypertension, and limited cutaneous scleroderma; plus an esophagram demonstrating hypomotility. This review contains 11 highly rendered figures, 3 tables, and 72 references.

A CASE REPORT: KAZABACH-MERRITT SYNDROME (KMS)

Vestnik ◽  
2021 ◽  
pp. 73-77
Author(s):  
Г.Ж. Бодыков ◽  
Г.Н. Балмагамбетова ◽  
С.А. Лисогор ◽  
В.М. Шмонин
Keyword(s):  
Differential Diagnosis ◽  
Case Report ◽  
Early Diagnosis ◽  
Clinical Laboratory ◽  
Clinical Manifestations ◽  
Vascular Anomalies ◽  
Diagnosis And Treatment ◽  
Pediatric Practice

Синдром Казабаха - Мерритта в детской практике встречается крайне редко. Клинические проявления многообразны, что затрудняет своевременную диагностику и лечение данного заболевания. Цель: привлечь внимание неонатологов и педиатров к своевременной диагностике редких гематологических синдромов. Материалы и методы. Проведено расширенное обследование ребенка и тщательная дифференциальная диагностика с другими сосудистыми аномалиями. Результаты. На основании оценки анамнеза, клинико - лабораторных и инструментальных методов обследования установлен диагноз СКМ. Выводы. Постановка диагноза СКМ требует проведения расширенного обследования ребенка и тщательной дифференцировки с другими сосудистыми аномалиями. Kazabach-Merritt syndrome is extremely rare in pediatric practice. Clinical manifestations are diverse- and this fact complicates the early diagnosis and treatment of the disease.Purpose: to draw the attention of neonatologists and pediatricians to the early diagnosis of rare hematological syndromes.Materials and methods. An extended examination of the child and a thorough differential diagnosis with other vascular anomalies were carried out. Results. The KMS was diagnosed on the base of: the assessment of the anamnesis, clinical - laboratory and instrumental examination methods.Conclusion. The diagnosis of KMS requires an extended examination of the child and careful differentiation of other vascular anomalies.

scholarly journals BENIGN PAROXYSMAL POSITIONAL VERTIGO IN THE PRACTICE OF AMBULANCE DOCTOR

2019 ◽  
Vol 19 (4) ◽  
pp. 38-42
Author(s):  
V. A. Voronov ◽  
D. Yu. Demidenko ◽  
E. A. Levina ◽  
E. A. Moiseeva ◽  
Yu. A. Rudneva ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Benign Paroxysmal Positional Vertigo ◽  
Clinical Manifestations ◽  
Diagnosis And Treatment ◽  
Positional Vertigo ◽  
Common Causes ◽  
Paroxysmal Positional Vertigo

The article contains information on benign paroxysmal positional vertigo, which is one of the most common causes of dizziness. Data on etiology, epidemiology, clinical manifestations, diagnosis, differential diagnosis and treatment of this disease are presented.

Scleroderma and Related Disorders

2018 ◽  
Author(s):  
Kristine Phillips
Keyword(s):  
Differential Diagnosis ◽  
Antinuclear Antibodies ◽  
Clinical Course ◽  
Clinical Manifestations ◽  
Diagnosis And Treatment ◽  
Localized Scleroderma ◽  
Eosinophilic Fasciitis ◽  
Tomographic Images ◽  
Computed Tomographic

Scleroderma spectrum diseases are a heterogeneous group of disorders that are distinguished by abnormalities of the connective tissue in the skin and, in some cases, other organs. Each disorder may be characterized by the extent of cutaneous and internal involvement, as well as histopathologic features of skin biopsy. Scleroderma spectrum diseases include systemic scleroderma, localized scleroderma, and eosinophilic fasciitis. This chapter reviews the classification, epidemiology, etiology, pathophysiology and pathogenesis, diagnosis, differential diagnosis, treatment, outcome measures, management, and clinical course of scleroderma as well as the definition and classification, etiology/genetics, differential diagnosis, and treatment of localized scleroderma. Also discussed are the definition and classification, epidemiology, etiology/genetics/pathogenesis, diagnosis, differential diagnosis, and treatment of eosinophilic fasciitis. Tables review the classification of—and antinuclear antibodies in—scleroderma as well as the key assessments and interventions in scleroderma management. Figures illustrate the disease's presentation and clinical manifestations, including several images of scleroderma of the hands; face, palmar, and buccal telangiectasias in a patient with scleroderma; a radiograph demonstrating calcinosis of the elbow; Raynaud’s phenomenon; high-resolution computed tomographic images of diffuse cutaneous scleroderma, scleroderma and severe pulmonary hypertension, and limited cutaneous scleroderma; plus an esophagram demonstrating hypomotility. This review contains 11 highly rendered figures, 3 tables, and 72 references.

Petrous Apex Lesions: Differential Diagnosis and Treatment

Skull Base ◽  
2007 ◽  
Vol 16 (S 2) ◽  
Author(s):  
Anna Papadopoulou ◽  
Apostolos Papadopoulos ◽  
Giorgos Tzindros ◽  
Nikolaos Marangos
Keyword(s):  
Differential Diagnosis ◽  
Diagnosis And Treatment ◽  
Petrous Apex

PERANAN RADIOLOGI PADA KASUS TUMOR WILMS’

2020 ◽  
Vol 4 (1) ◽  
pp. 26-33
Author(s):  
Galuh Ayu Treswari ◽  
Bambang Soeprijanto ◽  
Indrastuti Normahayu ◽  
Lenny Violetta
Keyword(s):  
Differential Diagnosis ◽  
Distant Metastasis ◽  
Wilms Tumor ◽  
Diagnosis And Treatment ◽  
Tumor Extension ◽  
Abdominal Tumors ◽  
Pathology Reports

Wilms’ tumor is the most frequent renal malignancy in childhood with the highest incidence per year, approximately 7,8 cases per 1.000.000in children under 15 years-old and frequently occurred in 2-5 years of age (highest incidences in 3 years-old). There are many differential diagnosis of intra-abdominal tumors and the correct differential diagnosis are detrimental to the prescribed treatments for the patients.Medical imaging along with pathology reports is a precise way to determine the appropriate diagnosis and treatment. Imaging gives information about tumor extension and distant metastasis, especially useful for indicating pre-operative chemotherapy.

A glance on dystonias, how to recognize and handle them

2019 ◽  
pp. 22-29
Author(s):  
F. N. Mercan ◽  
E. Bayram ◽  
M. C. Akbostanci
Keyword(s):  
Differential Diagnosis ◽  
Movement Disorder ◽  
Age Of Onset ◽  
Clinical Manifestations ◽  
Body Part ◽  
Classification Model ◽  
Treatment Choices ◽  
Muscle Groups

Dystonia refers to an involuntary, repetitive, sustained, painful and twisting movements of the affected body part. This movement disorder was first described in 1911 by Hermain Oppenheim, and many studies have been conducted to understand the mechanism, the diagnosis and the treatment of dystonia ever since. However, there are still many unexplained aspects of this phenomenon. Dystonia is diagnosed by clinical manifestations, and various classifications are recommended for the diagnosis and the treatment. Anatomic classification, which is based on the muscle groups involved, is the most helpful classification model to plan the course of the treatment. Dystonias can also be classified based on the age of onset and the cause. These dystonic syndromes can be present without an identified etiology or they can be clinical manifestations of a neurodegenerative or neurometabolic disease. In this review we summarized the differential diagnosis, definition, classifications, possible mechanisms and treatment choices of dystonia.

Clinical manifestations, diagnosis and treatment of HIV infection of stage 4 (severely symptomatic stage) in the practice of a health professional

2020 ◽  
pp. 27-34
Author(s):  
A. Nikitina ◽  
A. Rusanova ◽  
A. Zhilenkova
Keyword(s):  
Hiv Infection ◽  
Health Professional ◽  
Clinical Picture ◽  
Clinical Manifestations ◽  
Significant Problem ◽  
Diagnosis And Treatment ◽  
Modern World ◽  
Infected People ◽  
Stage 4 ◽  
Future Practice

HIV infection is a significant problem in the modern world, because there are more and more infected people every year. This article will consider: the clinical picture, diagnosis and treatment of this disease in different countries. Based on these data, the following conclusions will be made to help doctors in their future practice correctly approach the diagnosis and treatment of patients with this disease.

Sign in / Sign up

Export Citation Format

Share Document